Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of 226.29 billion as of February 6, 2026. Its market cap has increased by 7.58% in one year.

Market Cap

226.29B

Enterprise Value

226.54B

Revenue

17.11B

Ranking

n/a

PE Ratio

974.65

Stock Price

91.24

Market Cap Chart

Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 361.82M to 226.29B, an increase of 62,442.23%. That is a compound annual growth rate of 34.52%.

Market Cap History

Date	Market Cap	% Change
Feb 6, 2026	226.29B	-21.80%
Dec 31, 2025	289.36B	54.15%
Dec 31, 2024	187.71B	61.05%
Dec 29, 2023	116.56B	-24.59%
Dec 30, 2022	154.57B	36.78%
Dec 31, 2021	113.01B	44.11%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Rede D'Or São Luiz	91.65B
Raia Drogasil	46.56B
Hypera	14.97B
Fleury	9.23B
Odontoprev	6.46B
Diagnósticos da América	5.27B
Empreendimentos Pague Menos	4.19B
Oncoclínicas do Brasil Serviços Médicos	2.78B

Market Cap Rankings